EMA Authorised: Teizeild (teplizumab) — Sanofi Winthrop Industrie

View source ↗

Summary

The European Medicines Agency authorised Teizeild (teplizumab) from Sanofi Winthrop Industrie for the treatment of Type 1 diabetes mellitus.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 1 Diabetes Mellitus

Drugs mentioned

• Teizeild

Snippet

Status: Authorised. Therapeutic area: Diabetes Mellitus, Type 1. MAH: Sanofi Winthrop Industrie. Decision date: 08/01/2026